Interleukin-4

Growth Factors and Cytokines in Health and Disease

Volumn 2, Issue C, 1997, Pages 85-142

  Banchereau, Jacques ^a   Saeland, Sem ^a  

^a Schering Plough Laboratory for Immunological Research Dardilly   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 6544257519     PISSN: 18745687     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5687(97)80024-9     Document Type: Review

References (343)

1. Abe E., De Waal Malefyt R., Matsuda I., Arai K., and Arai N. An 11-base-pair DNA sequence motif apparently unique to the human interleukin 4 gene confers responsiveness to T-cell activation signals. PNAS 89 (1992) 2864-2868
2. Abramson S.L., and Gallin J.I. IL-4 inhibits superoxide production by human mononuclear phagocytes. J. Immunol. 144 (1990) 625-630
3. Akashi K., Harada M., Shibuya T., Eto T., Takamatsu Y., Teshima T., and Niho Y. Effects of interleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34- blasts from acute myelogenous leukemia. Blood 78 (1991) 197-204
4. Akashi K., Shibuya T., Harada M., Takamatsu Y., Uike N., Eto T., and Niho Y. Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells. J. Clin. Invest. 88 (1991) 223-230
5. Allen J.B., Wong H.L., Costa G.L., Bienkowski M.J., and Wahl S.M. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J. Immunol. 151 (1993) 4344-4351
6. Alzona M., Jäck H.M., Fisher R.I., and Ellis T.M. CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J. Immunol. 153 (1994) 2861-2867
7. Alzona M., Jäck H.M., Fisher R.I., and Ellis T.M. IL-12 activates IFN-γ production through the preferential activation of CD30+ T cells. J. Immunol. 154 (1995) 9-16
8. Arase H., Arase N., Nakagawa K., Good R.A., and Onoe K. NK1.1+ CD4+ CD8+ thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23 (1993) 307-310
9. Armitage R.J., Goff L.K., and Beverley P.C.L. Expression and functional role of CD23 on T cells. Eur. J. Immunol. 19 (1989) 31-35
10. Arruda S., and Ho J.L. IL-4 receptor signal transduction in human monocytes is associated with protein kinase C translocation. J. Immunol. 149 (1992) 1258-1264
11. Asano Y., Shibuya T., Okamura S., Yamaga S., Otsuka T., and Niho Y. Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells. Cancer Res. 47 (1987) 5647-5648
12. Autran B., Legac E., Blanc C., and Debré P. A ThO/Th2-like function of CD4+ CD7- T helper cells from normal donors and HIV-infected patients. J. Immunol. 154 (1995) 1408-1417
13. Aversa G., Punnonen J., Cocks B.J., de Waal Malefyt R., Vega F., Zurawski S.M., Zurawski G., and de Vries J.E. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: Support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med. 178 (1993) 2213-2218
14. Banchereau J., de Paoli P., Vallé A., Garcia E., and Rousset F. Long term human B cell lines dependent on interleukin 4 and antibody to CD40. Science 251 (1991) 70-72
15. Banchereau J., Bazan F., Blanchard D., Brière F., Galizzi J.-P., van Kooten C., Liu Y.-J., Rousset F., and Saeland S. The CD40 antigen and its ligand. Ann. Rev. Immunol. 12 (1994) 881-922
16. Barber D.L., and D'Andrea A.D. Erytropoietin and interleukin-2 activate distinct JAK kinase family members. Mol. Cel. Biol. 14 (1994) 6506-6514
17. Barcena A., Toribio M.L., Pezzi L., and Martinez-A C. A role for interleukin 4 in the differentiation of mature T cell receptor γ/δ+ cells from human intrathymic T cell precursors. J. Exp. Med. 172 (1990) 439-446
18. Baskar P., Silberstein D.S., and Pincus S.H. Inhibition of IgG-triggered human eosinophil function by IL-4. J. Immunol. 144 (1990) 2321-2326
19. Bazan J.F. Haemopoietic receptors and helical cytokines. Immunol. Today 11 (1990) 350-354
20. Billips L., Petitte D., and Landreth K.S. Bone marrow stromal cell regulation of B lymphopoiesis: Interleukin-1 (IL-1) and IL-4 regulate stromal cell support of pre-B cell production in vitro. Blood 75 (1990) 611-619
21. Billips L.G., Petitte D., Hostutler R., Tsai P., and Landreth K.S. Suppression of bone marrow stromal cell function. Ann. NY Acad. Sci. 628 (1991) 313-322
22. Blay J.Y., Branellec D., Robinet E., Dugas B., Gay F., and Chouaib S. Involvement of cAMP in the IL-4 inhibitory effect on IL-2 induced LAK generation. J. Clin. Invest. 85 (1990) 1909-1913
23. Bober L.A., Waters T.A., Pugliese-Sivo C.C., Sullivan L.M., Narula S.K., and Grace M.J. IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils. Clin. Exp. Immunol. 99 (1995) 129-136
24. Bochner B.S., Klunk D.A., Sterbinsky S.A., Coffman R.L., and Schleimer R.P. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J. Immunol. 154 (1995) 799-803
25. Boey H., Rosenbaum R., Castracane J., and Borish L. Interleukin-4 is a neutrophil activator. J. Allergy Clin. Immunol. 83 (1989) 978-984
26. Boguniewicz M., Jaffe H.S., Izu A., Sullivan M.J., York D., Geha R.S., and Leung D.Y.M. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am. J. Med. 88 (1990) 365-370
27. Bosco M.C., Giovarelli M., Forni M., Modesti A., Scarpa G., Masuelli L., and Forni G. Low doses of interleukin 4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J. Immunol. 145 (1990) 3136-3143
28. Bradding P., Feather I.H., Howarth P.H., Mueller R., Roberts J.A., Britten K., Bews J.P.A., Hunt T.G., Okayama Y., and Heusser C.H. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176 (1992) 1381-1386
29. Briscoe D.M., Cotran R.S., and Pober J.S. Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration. J. Immunol. 149 (1992) 2954-2960
30. Brown M.A., Pierce J.H., Watson C.J., Falco J., Ihle J.N., and Paul W.E. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 50 (1987) 809-818
31. Broxmeyer H.E., Lu L., Cooper S., Tushinski R., Mochizuki D., Rubin B.Y., Gillis S., and William D.E. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. J. Immunol. 141 (1988) 3852-3862
32. Brunn G.J., Falls E.L., Nilson A.E., and Abraham R.T. Protein-tyrosine kinase-dependent activation of STAT transcription factors in interleukin-2- or interleukin-4-stimulated T lymphocytes. J. Biol. Chem. 270 (1995) 11628-11635
33. Brunner T., Heusser C.H., and Dahinden C.A. Human peripheral blood basophils primed by interleukin-3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med. 177 (1993) 605-611
34. Cabrillat H., Galizzi J.P., Djossou O., Arai N., Yokota T., Arai K., and Banchereau J. High affinity binding of human interleukin 4 to cell lines. Biochem. Biophys. Res. Commun. 149 (1987) 995-1001
35. Claman H.N., and Spiegelberg H.L. Immunoglobulin dysregulation in murine graft-versus-host disease: A hyper-IgE syndrome. Clin. Immunol. Immunopathol. 56 (1990) 46-53
36. 2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14 (1993) 107-111
37. Coffman R.L., Ohara J., Bond M.W., Carty J., Zlotnick A., and Paul W.E. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J. Immunol. 136 (1986) 4538-4541
38. Coffman R.L., Varkila K., Scott P., and Chatelain R. Role of cytokines in the differentiation of CD4+ T cell subsets in vivo. Immunol. Rev. 123 (1991) 189-207
39. Colotta F., Sironi M., Borrè A., Luini W., Maddalena F., and Mantovani A. Interleukin 4 amplifies monocyte chemotactic protein and interleukin 6 production by endothelial cells. Cytokine 4 (1992) 24-28
40. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., Giri J.G., Dower S.K., Sims J.E., and Mantovani A. Interleukin-1 Type II receptor: as a decoy target for IL-1 that is regulated by IL-4. Science 261 (1993) 472-475
41. 2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 267 (1992) 515-519
42. Crawford R.M., Finbloom D.S., Ohara J., Paul W.E., and Meltzer M.S. B cell stimulatory factor-1 (interleukin-4) activates macrophages for increased tumouricidal activity and expression of Ia antigens. J. Immunol. 139 (1987) 135-141
43. de Wit H., Hendriks D.W., Halie M.R., and Vellenga E. Interleukin-4 receptor regulation in human monocytic cells. Blood 84 (1994) 608-615
44. Dechanet J., Briolay J., Rissoan M.-C., Chomarat P., Galizzi J.-P., Banchereau J., and Miossec P. Interleukin 4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J. Immunol. 151 (1993) 4908-4917
45. Dechanet J., Taupin J.L., Chomarat P., Rissoan M.C., Moreau J.F., Banchereau J., and Miossec P. Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur. J. Immunol. 24 (1994) 3222-3228
46. Defrance T., Aubry J.P., Rousset F., Vanbervliet B., Bonnefoy J.Y., Arai N., Takebe Y., Yokota T., Lee F., Arai K., De Vries J., and Banchereau J. Human recombinant interleukin 4 induces Fce{open} receptors (CD23) on normal human B lymphocytes. J. Exp. Med. 165 (1987) 1459-1467
47. Defrance T., Vanbervliet B., Aubry J.P., Takebe Y., Arai N., Miyajima A., Yokota T., Lee T., Arai K., de Vries J.E., and Banchereau J. B cell growth-promoting activity of recombinant human interleukin-4. J. Immunol. 139 (1987) 1135-1141
48. Defrance T., Vanbervliet B., Aubry J.P., and Banchereau J. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2. J. Exp. Med. 168 (1988) 1321-1337
49. Del Prete G., De Carli M., Almerigogna F., Daniel C.K., D'Elios M.M., Zancuochi G., Vinante F., Pizzolo G., and Romagnani S. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J. 9 (1995) 81-86
50. Del Prete G., Maggi E., Pizzolo G., and Romagnani S. CD30, Th2 cytokines and HIV infection: A complex and fascinating link. Immunol. Today 16 (1995) 76-80
51. Deng W., Ohmori Y., and Hamilton T.A. Mechanisms of IL-4-mediated suppression of IP-gene expression in murine macrophages. J. Immunol. 153 (1994) 2130-2136
52. Denis M., and Ghadirian E. Interleukin 13 and interleukin 4 protect bronchoalveolar macrophages from productive infection with human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 10 (1994) 795-802
53. Dokter W.H.A., Borger P., Hendriks D., van der Horst I., Halie M.R., and Vellenga E. Interleukin-4 (IL-4) receptor expression on human T cells is affected by different intracellular signaling pathways and by IL-4 at transcriptional and posttranscriptional level. Blood 80 (1992) 2721-2728
54. Dokter W.H.A., Esselink M.T., Halie M.R., and Vellenga E. Interleukin-4 inhibits the lipopolysaccharide-induced expression of c-jun and c-fos messenger RNA and activator protein-1 binding activity in human monocytes. Blood 81 (1993) 337-343
55. Dokter W.H.A., Esselink M.T., Sierdsema S.J., Halie M.R., and Vellenga E. Transcriptional and posttranscriptional regulation of the interleukin-4 and interleukin-3 genes in human T cells. Blood 81 (1993) 35-40
56. Dokter W.H.A., Sierdsema S.J., Esselink M.T., Halie M.R., and Vellenga E. Interleukin-4-mediated inhibition of c-fos mRNA expression: Role of the lipoxygenase directed pathway. Leukemia 8 (1994) 1181-1184
57. Egger D., Geuenich S., Denzlinger C., Schmitt E., Mailhammer R., Ehrenreich H., Dörmer P., and Hültner L. IL-4 renders mast cells functionally responsive to Endothelin-1. J. Immunol. 154 (1995) 1830-1837
58. Elson L.H., Shaw S., Van Lier R.A.W., and Nutman T.B. T cell subpopulation phenotypes in filarial infections: CD27 negativity defines a population greatly enriched for Th2 cells. Int. Immunol. 6 (1994) 1003-1009
59. Elson L.H., Nutman T.B., Metcalfe D.D., and Prussin C. Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+ CD27- lymphocyte subpopulation. J. Immunol. 154 (1995) 4294-4301
60. Erard F., Wild M.-T., Garcia-Snaz J.A., and Le Gros G. Switch of CD8 T cells to noncytolytic CD8- CD4- cells that make Th2 cytokines and help B cells. Science 260 (1993) 1802-1805
61. Estrov Z., Markowitz A.B., Kurzrock R., Wetzler M., Kantarjian H.M., Ferrajoli A., Gutterman J.U., and Talpaz M. Suppression of chronic myelogenous leukemia colony growth by interleukin-4. Leukemia 7 (1993) 214-220
62. Fanslow W.C., Sims J.E., Sassenfeld H., Morrissey P.J., Gillis S., Dower S.K., and Widmer M. Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor. Science 248 (1990) 739-742
63. Fanslow W.C., Clifford K.N., Park L.S., Rubin A.S., Voice R.F., Beckmann M.P., and Widmer M.B. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J. Immunol. 147 (1991) 535-540
64. Fanslow W.C., Spriggs M.K., Rauch C.T., Clifford K.N., Macduff B.M., Ziegler S.F., Schooley K.A., Mohler K.M., March C.J., and Armitage R.J. Identification of a distinct low-affinity receptor for human interleukin-4 on pre-B cells. Blood 81 (1993) 2998-3005
65. Favre C., Saeland S., Caux C., Duvert V., and De Vries J.E. Interleukin 4 has basophilic and eosinophilic cell growth-promoting activity on cord blood cells. Blood 75 (1990) 67-73
66. Feghali C.A., Bost K.L., Boulware D.W., and Levy L.S. Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblasts. Clin. Immunol. Immunopathol. 63 (1992) 182-187
67. Fernandez-Botran R., and Vitetta E.S. A soluble, high-affinity, interleukin-4 binding protein is present in the biological fluids of mice. Proc. Natl. Acad. Sci. USA 87 (1990) 4202-4206
68. Fernandez-Botran R., and Vitetta E.S. Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. J. Exp. Med. 174 (1991) 673-681
69. Fertin C., Nicolas J.F., Gillery P., Kalis B., Banchereau J., and Maquart F.X. Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents. Cell. Mol. Biol. 37 (1991) 823-829
70. Finkelman F.D., Holmes J., Katona I.M., Urban J.F., Beckmann M.P., Schooley K.A., Coffman R.L., Mosmann T.R., and Paul W.E. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8 (1990) 303-333
71. Finkelman F.D., Svetic A., Gresser I., Snapper C., Holmes J., Trotta P.P., Katona I.M., and Gause W.C. Regulation by interferon α of immunoglobulin isotype selection and lymphokine production in mice. J. Exp. Med. 174 (1991) 1179-1188
72. Finney M., Guy G.R., Michell R.H., Gordon J., Dugas B., Rigley K.P., and Callard R.E. Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generation. Eur. J. Immunol. 20 (1990) 151-156
73. Fiorentino D.F., Bond M.W., and Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170 (1989) 2081-2095
74. Foxwell B.M.J., Woerly G., and Ryffel B. Identification of interleukin-4 receptor-associated proteins and expression of both high and low affinity binding on human lymphoid cells. Eur. J. Immunol. 19 (1989) 1637-1641
75. Freeman G.J., Boussiotis V.A., Anumanthan A., Bernstein G.M., Ke X.Y., Rennert P.D., Gray G.S., Gribben J.G., and Nadler L.M. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2 (1995) 523-532
76. Gajewski T.F., Joyce J., and Fitch F.W. Anti-proliferative effect of IFN-γ in immune regulation. III. Differential selection of Th1 and Th2 murine helper T lymphocyte clones using recombinant IL-2 recombinant IFN-γ. J.Immunol. 143 (1989) 15-22
77. Galizzi J.-P., Zuber C.E., Cabrillat H., Djossou O., and Banchereau J. Internalization of human interleukin 4 and transient down-regulation of its receptor in the CD23-inducible Jijoye cells. J. Biol. Chem. 264 (1989) 6984-6989
78. Galizzi J.-P., Castle B., Djossou O., Harada N., Cabrillat H., Ait Yahia S., Barrett R., Howard M., and Banchereau J. Purification of a 130-kDa T cell glycoprotein that binds human interleukin 4 with high affinity. J. Biol. Chem. 265 (1990) 439-444
79. Galizzi J.P., Zuber C.E., Harada N., Gorman D.M., Djossou O., Kastelein R., Banchereau J., Howard M., and Miyajima A. Molecular cloning of a cDNA encoding the human interleukin-4 receptor. Int. Immunol. 2 (1990) 669-675
80. Galy A.H., and Spits H. IL-1, IL-4, and IFN-γ differentially regulate cytokine production and cell surface molecule expression in cultured human thymic epithelial cells. J. Immunol. 147 (1991) 3823-3830
81. Garret D.S., Powers R., March C.J., Frieden E.A., Clore G.M., and Gronenborn A.M. Determination of the secondary structure and folding topology of human interleukin-4 using three-dimensional heteronuclear magnetic resonance spectroscopy. Biochemistry 31 (1992) 4347-4353
82. Garrone P., Djossou O., Galizzi J.P., and Banchereau J. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes. Eur. J. Immunol. 21 (1991) 1365-1369
83. Gascan H., Gauchat J.-F., Roncarolo M.-G., Yssel H., Spits H., and de Vries J.E. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J. Exp. Med. 173 (1991) 747-750
84. Gautam S.C., Chikkala N.F., and Hamilton T.A. Anti-inflammatory action of IL-4. J. Immunol. 148 (1992) 1411-1415
85. Gaya A., Alsinet E., Martorell J., Places L., De La Calle O., Yagüe J., and Vives J. Inhibitory effect of IL-4 on the sepharose-CD3-induced proliferation of the CD4CD45RO human T cell subset. Int. Immunol. 2 (1990) 685-689
86. Gilleece M.H., Scarffe J.H., and Ghosh A. Recombinant human interleukin-4 (IL-4) given as daily subcutaneous injections-a phase I dose toxicity trial. Br. J. Cancer 66 (1992) 204-210
87. Gillery P., Fertin C., Nicolas J.F., Chastang F., Kalis B., Banchereau J., and Maquart F.X. Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. FEBS Lett. 302 (1992) 231-234
88. Golumbek P.T., Lazenby A.J., Levitsky H.I., Jaffee L.M., Karasuyama H., Baker M., and Pardoll D.M. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254 (1991) 713-716
89. Grabstein K., Eisenman J., Mochizuki K., Shanebeck K., Conlon P., Hopp T., March C., and Gillis S. Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines. J. Exp. Med. 163 (1986) 1405-1414
90. Greil J., Gramatzki M., Burger R., Marschalek R., Peltner M., Trautmann U., Hansen-Hagge T.E., Bartram C.R., Fey G.H., Stehr K., and Beck J. The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7. Br. J. Haematol. 86 (1994) 275-283
91. Grunfeld C., Soued M., Adi S., Moser A.H., Fiers W., Dinarello C.A., and Feingold K.R. Interleukin-4 inhibits stimulation of hepatic lipogenegis by tumor necrosis factor, interleukin-1 and interleukin-6 but not interferon-α. Cancer Res. 51 (1991) 2803-2807
92. Gruss H.J., and Dower S.K. Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood 85 (1995) 3378-3404
93. Hamaguchi Y., Kanakura Y., Fusita J., Takeoa S.I., Nakano T., Tarui S., Honjo T., and Kitamura Y. Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells. J. Exp. Med. 165 (1987) 268-273
94. Harada N., Yang G., Miyajima A., and Howard M. Identification of an essential region for growth signal transduction in the cytoplasmic domain of the human interleukin-4 receptor. J. Biol. Chem. 267 (1992) 22752-22758
95. Harel-Bellan A., Durum S., Muegge K., Abbas A.K., and Farrar W.L. Specific inhibition of lymphokine biosynthesis and autocrine growth using antisense oligonucleotides in Th1 and Th2 helper T cell clones. J. Exp. Med. 168 (1988) 2309-2318
96. Hart P.H., Vitti G.F., Burgess D.R., Whitty G.A., Piccoli D.S., and Hamilton J.A. Potential anti-inflammatory effects of interleukin 4: Suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc. Natl. Acad. Sci. USA 86 (1989) 3803-3807
97. He Y.W., and Malek T.R. The IL-2 receptor γc chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor. J. Immunol. 155 (1995) 9-12
98. Heyd J., Donnenberg A.D., Burns W.H., Segal R., and Santos G.W. Immunoglobulin IgE levels following allogeneic, autologous and syngeneic bone marrow transplantation: An indirect association between hyperproduction and acute graft-versus-host disease in allogeneic BMT. Blood 72 (1988) 442-446
99. Ho J.L., He S.H., Rios M.J., and Wick E.A. Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity. J. Inf. Diseases 165 (1992) 344-351
100. Hofman F.M., Brock M., Taylor C.R., and Lyons B. IL-4 regulates differentiation and proliferation of human precursor B cells. J. Immunol. 141 (1988) 1185-1190
101. Horohov D.W., Crim J.A., Smith P.L., and Siegel J.P. IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity. J. Immunol. 141 (1988) 4217-4223
102. Hou J., Schindler U., Henzel W.J., Ho T.C., Brasseur M., and McKnight S.L. An interleukin-4-induced transcription factor: IL-4 stat. Science 265 (1994) 1701-1706
103. Howard M., Farrar J., Hilfiker M., Johnson B., Takatsu K., Hamaoka T., and Paul W.E. Identification of a T-cell derived B cell growth factor distinct from interleukin-2. J. Exp. Med. 155 (1982) 914-921
104. Howells G., Pham P., Taylor D., Foxwell B., and Feldman M. Interleukin 4 induces interleukin 6 production by endothelial cells: Synergy with interferon-γ. Eur. J. Immunol. 21 (1991) 97-101
105. Hu-Li J., Shevach E.M., Mizuguchi J., Ohara J., Mosmann T., and Paul W.E. B cell stimulatory factor 1 (interleukin 4 is a potent costimulant for normal resting T lymphocytes. J. Exp. Med. 165 (1987) 157-172
106. Hurford R.K., Dranoff G., Mulligan R.C., and Tepper R.I. Gene therapy of metastatic cancer by in vivo retroviral gene targeting. Nature Genetics 10 (1995) 430-435
107. Iademarco M.F., Barks J.L., and Dean D.C. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J. Clin. Invest. 95 (1995) 264-271
108. Ichiki T., Takahashi W., and Watanabe T. Regulation of the expression of human Cε germline transcript. J. Immunol. 150 (1993) 5408-5417
109. Idzerda R.L., March C.J., Mosley B., Lyman S.D., Vanden Bos T., Gimpel S.D., Din W.S., Grabstein K.H., Widmer M.B., Park L.S., Cosman D., and Beckmann M.P. Human Interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J. Exp. Med. 171 (1990) 861-873
110. Ihle J.N., Witthuhn B.A., Quelle F.W., Yamamoto K., and Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13 (1995) 369-398
111. Imai Y., Tohda S., Nagata K., Suzuki T., Nara N., and Aoki N. Effects of recombinant interleukin 4 on the growth and differentiation of blast progenitors stimulated with G-CSF, GM-CSF and IL-3 from acute myeloblastic leukaemia patients. Br. J. Haematol. 78 (1991) 173-179
112. Isacksson P.C., Pure E., Vitetta S., and Krammer P.H. Effect on the isotype switch of murine B cells. J. Exp. Med. 155 (1982) 734-748
113. Izuhara K., Feldman R.A., Greer P., and Harada N. Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor. J. Biol. Chem. 269 (1994) 18623-18629
114. Izuhara K., and Harada N. Interleukin-4 (IL-4) induces protein tyrosine phosphorylation of the IL-4 receptor and association of phosphatidylinositol 3-kinase to the IL-4 receptor in a mouse T cell line, HT2. J. Biol. Chem. 268 (1993) 13097-13102
115. Jabara H.H., Fu S.M., Geha R.S., and Vercelli D. CD40 and IgE: Synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172 (1990) 1861-1864
116. Jabara H.H., Loh R., Ramesh N., Vercelli D., and Geha R.S. Sequential switching from μ to epsilon via gamma4 in human B cells stimulated with IL-4 and hydrocortisone. J. Immunol. 151 (1993) 4528
117. Jansen J.H., Wientjens G.-J.H.M., Fibbe W.E., Willemze R., and Kluin-Nelemans H.C. Inhibition of human macrophage colony formation by interleukin 4. J. Exp. Med. 170 (1989) 577-582
118. Jansen J.H., Fibbe W.E., Wientjens G.J.H.M., Van Damme J., Landegent J.E., Willemze R., and Kluin-Nelemans J.C. Interleukin 4 down-regulates the expression of CD14 and the production of interleukin 6 in acute myeloid leukemia cells. Lymph. Cyt. Res. 10 (1991) 457-461
119. Jelinek D.F., and Lipsky P.E. Inhibitory influence of IL-4 on human B cell responsiveness. J. Immunol. 141 (1988) 164-173
120. 2+ mobilization, protein kinase C translocation, or membrane depolarization in resting murine B lymphocytes. J. Immunol. 137 (1986) 3664-3670
121. Jutel M., Pichler W.J., Skrbic D., Urwyler A., Dahinden C., and Müller U.R. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J. Immunol. 154 (1995) 4187-4194
122. Kalinski P., Hilkens C.M.U., Wierenga E.A., Van der Pouw-Kraan T.C.T.M., Van Lier R.A.W., Bos J.D., Kapsenberg M.L., and Snijdewint F.G.M. Functional maturation of human naive T helper cells in the absence of accessory cells. J. Immunol. 154 (1995) 3753-3760
123. Kapiotis S., Besemer J., Bevec D., Valent P., Bettelheim P., Lechner K., and Speiser W. Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells. Blood 78 (1991) 410-415
124. Kapsenberg M.L., Wierenga E.A., Bos J.D., and Jansen H.M. Functional subsets of allergen-reactive human CD4+ T cells. Immunol. Today 12 (1991) 392-395
125. Kapsenberg M.L., Wierenga E.A., Van Der Heijden F.L., and Bos J.D. Atopic dermatitis and CD4+ atopen-specific Th2 lymphocytes. Eur. J. Dermatol. 8 (1992) 601-607
126. Karray S., Dautry-Varsat A., Tsudo M., Merle-Beral H., Debré P., and Galanaud P. IL-4 inhibits the expression of high affinity IL-2 receptors on monoclonal human B cells. J. Immunol. 145 (1990) 1152-1158
127. Katz J.D., Benoist C., and Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 268 (1995) 1185-1188
128. Kawahara A., Minami Y., and Taniguchi T. Evidence for a critical role for the cytoplasmic region of the interleukin-2 (IL-2) receptor γ chain in IL-2, IL-4, and IL-7 signalling. Mol. Cel. Biol. 14 (1994) 5433-5440
129. Kawakami Y., Custer M.C., Rosenberg S.A., and Lotze M.T. IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. J. Immunol. 142 (1989) 3452-3461
130. Keegan A.D., and Pierce J.H. The interleukin-4 receptor: Signal transduction by a hematopoietin receptor. J. Leuk. Biol. 55 (1994) 272-279
131. Keegan A.D., Beckmann M.P., Park L.S., and Paul W.E. The IL-4 receptor: Biochemical characterization of IL-4-binding molecules in a T cell line expressing large numbers of receptors. J. Immunol. 146 (1991) 2272-2279
132. Keegan A.D., Nelms K., Wang L.M., Pierce J.H., and Paul W.E. Interleukin-4 receptor: Signaling mechanisms. Immunol. Today 15 (1994) 423-432
133. Keegan A.D., Nelms K., White M., Wang L.M., Pierce J.H., and Paul W.E. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76 (1994) 811-820
134. Keller U., Aman M.J., Derigs G., Huber C., and Peschel C. Human interleukin-4 enhances stromal cell-dependent hematopoiesis: Costimulation with stem cell factor. Blood 84 (1994) 2189-2196
135. Kinashi T., Inaba K., Tsubata T., Tashiro K., Palacios R., and Honjo T. Differentiation of an interleukin 3-dependent precursor B-cell clone into immunoglobulin-producing cells in vitro. Proc. Natl. Acad. Sci. USA 85 (1988) 4473-4477
136. Kinashi T., Tashiro K., Inaba K., Takeda T., Palacios R., and Honjo T. An interleukin-4-dependent precursor clone is an intermediate of the differentiation pathway from an interleukin-3-dependent precursor clone into myeloid cells as well as B lymphocytes. Int. Immunol. 1 (1989) 11-19
137. King A.G., Wierda D., and Landreth K.S. Bone marrow stromal cell regulation of B- lymphopoiesis. I. The role of macrophages, IL-1, and IL-4 in pre-B cell maturation. J. Immunol. 141 (1988) 2016-2026
138. King A.G., Landreth K.S., and Wierda D. Bone marrow stromal cell regulation of B-lymphopoiesis. II. Mechanisms of hydroquinone inhibition of pre-B cell maturation. J. Pharm. Exp. Ther. 250 (1989) 582-590
139. King C.L., Gallin J.I., Malech H.L., Abramson S.T., and Nutman T.B. Regulation of immunoglobulin production in hyperimmuno-globulin E recurrent-infection syndrome by interferon γ. Proc. Natl. Acad. Sci. USA 86 (1989) 10085-10089
140. Klein N.J., Rigley K.P., and Callard R.E. IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: Relationship between vimentin and CD23. Intern. Immunol. 5 (1993) 293-301
141. Koettnitz K., and Kalthoff F.S. Human interleukin-4 receptor signalling requires sequences contained within two cytoplasmic regions. Eur. J. Immunol. 23 (1993) 988-991
142. Kolb J.P., Paul-Eugène N., Damais C., Yamaoka K., Drapier J.C., and Dugas B. Interleukin-4 stimulates cGMP production by IFN-γ-activated human monocytes. J. Biol. Chem. 269 (1994) 9811-9816
143. Kondo M., Takeshita T., Ishii N., Nakamura M., Watanabe S., Arai K.-A., and Sugamura K. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 262 (1993) 1874-1877
144. Kotanides H., and Reich N.C. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 262 (1993) 1265-1267
145. Kruse N., Tony H.P., and Sebald W. Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement. EMBO J. 11 (1992) 3237-3244
146. Kühn R., Rajewsky K., and Müller W. Generation and analysis of interleukin-4 deficient mice. Science 254 (1991) 707-710
147. Kumaratilake L.M., and Ferrante A. IL-4 inhibits macrophage-mediated killing of Plasmodium Falciparum in vitro. J. Immunol. 149 (1992) 194-199
148. Lacey D.L., Erdmann J.M., Teitelbaum S.L., Tan H.L., Ohara J., and Shioi A. Interleukin-4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology 136 (1995) 2367-2376
149. Lacraz S., Nicod L., Galve-de-Rochemonteix B., Baumberger C., Dayer J.-M., and Welgus H.G. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 90 (1992) 382-388
150. Larner A.C., Petricoin E.F., Nakagawa Y., and Finbloom D.S. IL-4 attenuates the transcriptional activation of both IFN-α and IFN-γ-induced cellular gene expression in monocytes and monocytic cell lines. J. Immunol. 150 (1993) 1944-1950
151. Law C.-L., Armitage R.J., Villablanca J.G., and LeBien T.W. Expression of interleukin-4 receptors on early human B-lineage cells. Blood 78 (1991) 703-710
152. Lee F., Yokota T., Otsuka T., Meyerson P., Villaret D., Coffman R., Mosmann T., Rennick D., Roehm N., Smith C., Zlotnick A., and Arai K. Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T cell- and mast-cell-stimulating activities. Proc. Natl. Acad. Sci. USA 83 (1986) 2061-2065
153. Lehn M., Weiser W.Y., Engelhorn S., Gillis S., and Remold H.G. IL-4 inhibits H202 production and antileishmanial capacity of human cultured monocytes mediated by IFN-γ. J. Immunol. 143 (1989) 3020-3024
154. Lester M.R., Hofer M.F., Gately M., Trumble A., and Leung D.Y.M. Down-regulating effects of IL-4 and IL-10 on the IFN-γ response in atopic dermatitis. J. Immunol. 154 (1995) 6174-6181
155. Li-Weber M., Eder A., Krafft Czepa H., and Krammer P.H. T cell-specific negative regulation of transcription of the human cytokine IL-4. J. Immunol. 148 (1992) 1913-1918
156. Li-Weber M., Krafft H., and Krammer P.H. A novel enhancer element in the human IL-4 promoter is suppressed by a position-independent silencer. J. Immunol. 151 (1993) 1371-1382
157. Lin J.X., Migone T.S., Tsang M., Friedmann M., Weatherbee J.A., Zhou L., Yamauchi A., Bloom E.T., Mietz J., John S., and Leonard W.J. The role of shared receptor motifs and common stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15. Immunity 2 (1995) 331-339
158. Lind M., Deleuran B., Yssel H., Fink-Eriksen E., and Thestrup-Pedersen K. IL-4 and IL-13, but not IL-10, are chemotactic factors for human osteoblasts. Cytokine 7 (1995) 78-82
159. Linsley P.S., and Ledbetter J.A. The role of the CD28 receptor during T cell responses to antigen. Ann. Rev. Immunol. 11 (1993) 191-212
160. Llorente L., Mitjavila F., Crevon M.C., and Galanaud P. Dual effects of interleukin 4 on antigen-activated human B cells: induction of proliferation and inhibition of interleukin 2-dependent differentiation. Eur. J. Immunol. 20 (1990) 1887-1892
161. Lotze M.T. Role of IL-4 in the antitumor response. In: Spits H. (Ed). IL4: Structure and Function (1992), CRC Press Inc., New York 238-258
162. Loyer P., Ilyin G., Razzak Z.A., Dézier J.-F., Banchereau J., Campion J.-P., Guguen-Guillouzo C., and Guillouzo A. IL-4 modulates production of acute phase proteins in adult human hepatocytes. FEBS Lett. 336 (1993) 215-220
163. Maggi E., Giudizi M.G., Biagiotti R., Annunziato F., Manetti R., Piccinni M.-P., Parronchi P., Sampognaro S., Giannarini L., Zuccati G., and Romagnani S. Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med. 180 (1994) 489-495
164. Maggi E., Parronchi P., Manetti R., Simonelli C., Piccinni M.-P., Rugiu F.S., De Carli M., Ricci M., and Romagnani S. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J. Immunol. 148 (1992) 2142-2147
165. Malabarba M.G., Kirken R.A., Rui H., Koettnitz K., Kawamura M., O'Shea J.J., Kalthoff F.S., and Farrar W.L. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL-4) stimulated proliferation and requires a membrane-proximal region of IL-4 receptor alpha. J. Biol. Chem. 270 (1995) 9630-9637
166. Maliszewski C.R., Morrissey P.J., Fanslow W.C., Sato T.A., Willis C., and Devison B. Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor. Cell. Immunol. 143 (1992) 434-448
167. Manabe A., Coustan-Smith E., Behm F.G., Raimondi S.C., and Campana D. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 79 (1992) 2370-2377
168. Manabe A., Coustan-Smith E., Kumagai M.-A., Behm F.G., Raimondi S.C., Pui C.-H., and Campana D. Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia. Blood 83 (1994) 1731-1737
169. Manetti R., Annuziato F., Biagiotti R., Giudizi M.G., Piccinni M.P., Giannarini L., Sampognaro S., Parronchi P., Vinante F., Pizzolo G., Maggi E., and Romagnani S. CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+ CD30+ T cell clones in human immunodeficiency virus infection. J. Exp. Med. 180 (1994) 2407-2411
170. Manetti R., Gerosa F., Giudizi M.G., Biagiotti R., Parronchi P., Piccini M.P., Sampognaro S., Maggi E., Romagnani S., and Trinchieri G. Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J. Exp. Med. 179 (1994) 1273-1283
171. Mantovani A., Bussolino F., and Dejana E. Cytokine regulation of endothelial cell function. FASEB J. 6 (1992) 2591-2599
172. Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T.J., Galanaud P., and Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J. Immunol. 154 (1995) 1870-1878
173. Marsh D.G., Neely J.D., Breazeale D.R., Ghosh B., Freidhoff L.R., Ehrlich-Kautzky E., Schou C., Krishnaswamy G., and Beaty T.H. Linkage analysis of IL4 and other chromosome 5q31-1 markers and total serum immunoglobulin E concentrations. Science 264 (1994) 1152-1156
174. Masinovsky B., Urdal D., and Gallatin M.W. IL-4 acts synergistically with IL-1β to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion. J. Immunol. 145 (1990) 2886-2895
175. Matthews D.J., Clark P.A., Herbert J., Morgan G., Armitage R.J., Kinnon C., Minty A., Grabstein K.H., Caput D., Ferrara P., and Callard R. Function of the interleukin-2 (IL-2) receptor γ-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13 and IL-15. Blood 85 (1995) 38-42
176. McGarvie G.M., and Cushley W. The effect of recombinant interleukin 4 upon protein kinase activities associated with murine and human B lymphocyte plasma membranes. Cell Signal 1 (1989) 447-460
177. McInnes A., and Rennick D.M. Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells. J. Exp. Med 167 (1988) 598-611
178. McKenzie A.N.J., Culpepper J.A., de Waal Malefyt R., Brière F., Punnonen J., Aversa G., Sato A., Dang W., Cocks B.G., Menon S., de Vries J.E., Banchereau J., and Zurawski G. Interleukin-13, a novel T cell-derived cytokine that regulates human monocyte and B cell function. Proc. Natl. Acad. Sci. USA 90 (1993) 3735-3739
179. Migliorati G., Nicoletti I., Pagliacci M.C., D'Adamio L., and Riccardi C. Interleukin-4 protects double-negative and CD4 single-positive thymocytes from dexamethasone-induced apoptosis. Blood 81 (1993) 1352-1358
180. Mills F.C., Thyphronitis G., Finkelman F.D., and Max E.E. Immunoglobulin μ-ε isotype switch in IL-4 treated human B lymphoblastoid cells: Evidence for a sequential swtich. J. Immunol. 149 (1992) 1075-1085
181. Minty A., Chalon P., Derocq J.-M., Dumont X., Guillemot J.-C., Kaghad M., Labit C., Leplatois P., Liauzun P., Miloux B., Minty C., Casellas P., Loison G., Lupker J., Shire D., Ferrara P., and Caput D. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362 (1993) 248-250
182. Miossec P., Briolay J., Dechanet J., Wijdenes J., Martinez-Valdez H., and Banchereau J. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum. 35 (1992) 874-883
183. Miossec P., Chomarat P., Dechanet J., Moreau J.-F., Roux J.-P., Delmas P., and Banchereau J. Interleukin 4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum. 37 (1994) 1715-1722
184. Mire-Sluis A.R., and Thorpe R. Interleukin-4 proliferative signal transduction involves the activation of a tyrosine-specific phosphatase and the dephosphorylation of an 80-kDa protein. J. Biol. Chem. 266 (1991) 18113-18118
185. (suppl). Mitchell P., Clutterbuck R., Powles R., De Lord C., Titley J., and Millar J. Interleukin-4 (IL-4) improves survival and suppresses human ALL xenografts in SCID mice, confirming in vitro growth inhibition. Blood 84 (1994) 48a
186. Miyajima A., Kitamura T., Harada N., Yokota T., and Arai K. Cytokine receptors and signal transduction. Annu. Rev. Immunol. 10 (1992) 295-331
187. Miyauchi J., Clark S.C., Tsunematsu Y., Shimizu K., Park J.-W., Ogawa T., and Toyama K. Interleukin-4 as a growth regulator of clonogenic cells in acute myelogenous leukemia in suspension culture. Leukemia 5 (1991) 108-115
188. 2+). J. Immunol. 137 (1986) 2215-2219
189. Monroe J.G., Haldar S., Prystowsky M.B., and Lammie P. Lymphokine regulation of inflammatory processes: Interleukin-4 stimulates fibroblast proliferation. Clin. Immunol. Immunopathol. 49 (1988) 292-298
190. Montaner L.J., Doyle A.G., Collin M., Herbein G., Illei P., James W., Minty A., Caput D., Ferrara P., and Gordon S. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J. Exp. Med. 178 (1993) 743-747
191. Morgan J.G., Dolganov G.M., Robbins S.E., Hinton L.M., and Lovett M. The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes. Nucleic Acids Res. 20 (1992) 5173-5179
192. Moser R., Fehr J., and Bruijnzeel P.L.B. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J. Immunol. 149 (1992) 1432-1438
193. Mosley B., Beckmann M.P., March C.J., Idzerda R.L., Gimpel S.D., Vanden Bos T., Friend D., Alpert A., Anderson D., Jackson J., Wignall J.M., Smith C., Gallis B., Sims J.E., Urdal D., Widmer M.B., Cosman D., and Park L.S. The murine interleukin-4 receptor: Molecular cloning characterization of secreted and membrane bound forms. Cell 59 (1989) 335-348
194. Mosmann T.R., Bond M.W., Coffman R.L., Ohara J., and Paul W.E. T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc. Natl. Acad. Sci. USA 83 (1986) 5654-5658
195. Mueller R., Heusser C.H., Rihs S., Brunner T., Bullock G.R., and Dahinden C.A. Immunolocalization of intracellular interleukin-4 in normal human peripheral blood basophils. Eur. J. Immunol. 24 (1994) 2935-2940
196. Mulligan M.S., Jones M.L., Vaporciyan A.A., Howard M.C., and Ward P.A. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J. Immunol. 151 (1993) 5666-5674
197. Murakami M., Narazaki M., Hibi M., Yawata H., Yasukawa K., Hamaguchi M., Taga T., and Kishimoto T. A critical cytoplasmic region of the interleukin 6 signal transducer gp 130 is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. USA 88 (1991) 11349-11353
198. Musso T., Johnston J.A., Linnekin D., Varesio L., Rowe T.K., O'Shea J.J., and McVicar D.W. Regulation of JAK3 expression in human monocytes: Phosphorylation in response to interleukins 2, 4, and 7. J. Exp. Med. 181 (1995) 1425-1431
199. Nagler A., Lanier L.L., and Phillips J.H. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. J. Immunol. 141 (1988) 2349-2351
200. Noguchi M., Nakamura Y., Russel S.M., Ziegler S.F., Tsang M., Cao X., and Leonard W.J. Interleukin-2 receptor γ chain: A functional component of the interleukin-7 receptor. Science 262 (1993) 1877-1880
201. Noguchi M., Yi H., Rosenblatt H.M., Filipovich A.H., Adelstein S., Modi W.S., McBride O.W., and Leonard W.J. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73 (1993) 147-157
202. O'Garra A., and Spits H. The immunobiology of interleukin 4. Res. Immunol. 144 (1993) 567-643
203. Obiri N.I., Debinski W., Leonard W.J., and Puri R.K. Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for interleukins 2, 4, 7, 9 and 15. J. Biol. Chem. 270 (1995) 8797-8804
204. Obiri N.I., Hillman G.G., Haas G.P., Sud S., and Puri R.K. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J. Clin. Invest. 91 (1993) 88-93
205. 1-positive acute lymphoblastic leukemia cells. Blood 78 (1991) 1574-1580
206. Ouaaz F., Sola B., Issaly F., Kolb J.-P., Davi F., Mentz F., Arock M., Paul-Eugène N., Körner M., Dugas B., Debré P., and Mossalayi M.D. Growth arrest and terminal differentiation of leukemic myelomonocytic cells induced through ligation of surface CD23 antigen. Blood 84 (1994) 3095-3104
207. Paliard X., de Waal Malefijt R., de Vries J.E., and Spits H. Interleukin 4 can mediate the induction of CD8 on human CD4+ T cell clones. Nature 335 (1988) 642-644
208. Palmer-Crocker R.L., and Pober J.S. IL-4 induction of VCAM-1 on endothelial cells involves activation of a protein tyrosine kinase. J. Immunol. 154 (1995) 2838-2845
209. Pandrau D., Saeland S., Duvert V., Durand I., Manel A.M., Zabot M.T., Philippe N., and Banchereau J. Interleukin-4 inhibits in vitro proliferation of leukemic and normal human B cell precursors. J. Clin. Invest. 90 (1992) 1697-1706
210. Park L.S., Friend D., Sassenfeld H.M., and Urdal D.L. Characterization of the human B cell stimulatory factor 1 receptor. J. Exp. Med. 166 (1987) 476-488
211. Parronchi P., De Carli M., Manetti R., Simonelli C., Piccini M.P., Macchia D., Maggi E., Del Prete G., Ricci M., and Romagnani S. Aberrant interleukin (IL)4 and IL5 production in vitro by CD4+ helper T cells from atopic subjects. Eur. J. Immunol. 87 (1992) 58-69
212. Parronchi P., Macchia D., Piccini M.P., Biswas P., Simonelli C., Maggi E., Ricci M., Ansari A.A., and Romagnani S. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA 88 (1991) 4538-4542
213. Paul W.E. Interleukin-4: A prototypic immunoregulatory lymphokine. Blood 77 (1991) 1859-1870
214. Peleman R., Wu J., Fargeas C., and Delespesse G. Recombinant interleukin-4 suppresses the production of interferon γ by human mononuclear cells. J. Exp. Med. 170 (1989) 1751-1756
215. Pène J., Rousset F., Brière F., Chrétien I., Bonnefoy J.Y., Spits H., Yokota T., Arai N., Arai K.I., Banchereau J., and de Vries J.E. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc. Natl. Acad. Sci. USA 85 (1988) 6880-6884
216. Peschel C., Paul W.E., Ohara J., and Green I. Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells. Blood 70 (1987) 254-263
217. Peschel C., Green I., and Paul W.E. Preferential proliferation of immature B lineage cells in long-term stromal cell-dependent cultures with IL-4. J. Immunol. 142 (1989) 1558-1568
218. Phillips J.O., Everson M.P., Moldoveanu Z., Lue C., and Mestecky J. Synergistic effect of IL-4 and IFN-γ on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J. Immunol. 145 (1990) 1740-1744
219. Piccinni M.P., Macchia D., Parronchi P., Giudizi M.G., Bani D., Alterini R., Grossi A., Ricci M., Maggi E., and Romagnani S. Human bone marrow non-B, non-T cells produce IL-4 in response to cross-linkage of Fcε and Fcγ receptors. Proc. Natl. Acad. Sci. USA 88 (1991) 8656-8660
220. Piela-Smith T.H., Broketa G., Hand A., and Korn J.H. Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4. J. Immunol. 148 (1992) 1375-1381
221. Pizzolo G., Vinante F., Morosato L., Nadali G., Chilosi M., Gandini G., Sinicco A., Raiteri R., Semenzato G., Stein H., and Perona G. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 8 (1994) 741-745
222. Plum J., De Smedt M., Leclercq G., and Tison B. Inhibitory effect of murine recombinant IL-4 on thymocyte development in fetal thymus organ cultures. J. Immunol. 145 (1990) 1066-1073
223. Postlethwaite A.E., and Seyer J.M. Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. J. Clin. Invest. 87 (1991) 2147-2152
224. Postlethwaite A.E., Holness M.A., Katai H., and Raghow R. Human fibroblasts synthetize elevated levels of extracellular matrix proteins in response to interleukin 4. J. Clin. Invest. 90 (1992) 1479-1485
225. Powers R., Garrett D.S., March C.J., Frieden E.A., Gronenborn A.M., and Clore G.M. Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy. Science 256 (1992) 1673-1677
226. Prinz J.C., Baur X., Mazur G., and Rieber E.P. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin-4 and interferon-γ. Eur. J. Immunol. 20 (1990) 1259-1264
227. Punnonen J., Aversa G., and de Vries J.E. Human pre-B cells differentiate into Ig-secreting plasma cells in the presence of interleukin-4 and activated CD4+ T cells or their membranes. Blood 82 (1993) 2781-2789
228. Quelle F.W., Shimoda K., Thierfelder W., Fischer C., Kim A., Ruben S.M., Cleveland J.L., Pierce J.H., Keegan A.D., Nelms K., Paul W.E., and Ihle J.N. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cel. Biol. 15 (1995) 3336-3343
229. Racke M.K., Burnett D., Pak S.H., Albert P.S., Cannella B., Raine C.S., McFarlin D.E., and Scott D.E. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J. Immunol. 154 (1995) 450-458
230. Ramanathan L., Ingram R., Sullivan L., Greenberg R., Reim R., Trotta P.P., and Le H.V. Immunochemical mapping of domains in human interleukin 4 recognized by neutralizing monoclonal antibodies. Biochemistry 32 (1993) 3549-3556
231. Ranheim E.A., and Kipps T.J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177 (1993) 925-935
232. Rapoport M.J., Jaramillo A., Zipris D., Lazarus A.H., Serreze D.V., Leiter E.H., Cyopick P., Dnaska J.S., and Deloviqtch T.L. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178 (1993) 87-99
233. Razzak Z.A., Loyer P., Fautrel A., Gautier J.-C., Corcos L., Turlin B., Beaune P., and Guillouzo A. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Molec. Pharm. 44 (1993) 707-715
234. Reason D.C., Ebisawa M., Saito H., Nagakura T., and Likura Y. Interleukin 4 induces CD4+/CD8- to CD8+/CD4- transformation of human neonatal T cells by way of a double positive intermediate. Bioch. Biophys. Research Communications. 168 (1990) 830-836
235. Reddy M.M., Weissman A.M., Mazza D.S., Meriney D.K., Johns M., Carrabis S., and Grieco M.H. Circulating elevated levels of soluble CD23, interleukin 4, and CD20+ CD23+ lymphocytes in atopic subjects with elevated serum IgE concentrations. Ann. Allergy 69 (1992) 131-134
236. Renard N., Duvert V., Banchereau J., and Saeland S. Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors. Blood 84 (1994) 2253-2260
237. Rennick D.M., Moore J.G., and Thompson-Snipes L. IL-4 and hematopiesis. In: Spits H. (Ed). IL-4: Structure and Function (1992), CRC Press, New York 151-168
238. Rennick D., Yang G., Muller-Sieburg C., Smith C., Arai N., Takabe Y., and Gemmell L. Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells. Proc. Natl. Acad. Sci. USA 84 (1987) 6889-6893
239. Rigley K.P., Thurstan S.M., and Callard R.E. Independent regulation of interleukin 4 (IL-4)-induced expression of human B cell surface CD23 and IgM: Functional evidence for two IL-4 receptors. Int. Immunol. 3 (1991) 197-203
240. Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., and Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180 (1994) 83-93
241. Rousselet G., Busson P., Billaud M., Guillon J.M., Scamps C., Wakasugi H., Lenoir G., and Tursz T. Structure and regulation of the Blast-2/CD23 antigen in epithelial cells from nasopharyngeal carcinoma. Int. Immunol. 2 (1990) 1159-1166
242. Rousset F., Garcia E., and Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 173 (1991) 705-710
243. Rousset F., Robert J., Andary M., Bonnin J.P., Souillet G., Chrétien I., Brière F., Pène J., and de Vries J.E. Shifts in interleukin-4 and interferon-γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J. Allergy Clin. Immunol. 87 (1991) 58-69
244. Russel S.M., Keegan A.D., Harada N., Nakamura Y., Noguchi M., Leland P., Friedmann M.C., Miyajima A., Puri R.K., Paul W.E., and Leonard W.J. Interleukin-2 receptor γ chain: A functional component of the interleukin-4 receptor. Science 262 (1993) 1880-1883
245. Ryan D.H., Nuccie B.L., Ritterman I., Liesveld J.L., and Abboud C.N. Cytokine regulation of early human lymphopoiesis. J. Immunol. 152 (1994) 5250-5258
246. Sad S., Marcotte R., and Mosmann T.R. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2 (1995) 271-279
247. Saeland S., Duvert V., Moreau I., and Banchereau J. Human B cell precursors proliferate and express CD23 after CD40 ligation. J. Exp. Med. 178 (1993) 113-120
248. Salgame P., Abrams J.S., Clayberger C., Goldstein H., Convit J., Modlin R.L., and Bloom B.R. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254 (1991) 279-282
249. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179 (1994) 1109-1118
250. Sato T.A., Widmer M.B., Finkelman F.D., Madani H., Jacobs C.A., Grabstein K.H., and Maliszewski C.R. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J. Immunol. 150 (1993) 2717-2723
251. Schandene L., Ferster A., Mascart-Lemone F., Crusiaux A., Gerard C., Marchant A., Lybin M., Velu T., Sariban E., and Goldman M. T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur. J. Immunol. 23 (1993) 56-60
252. Schindler C., Kashleva H., Pernis A., Pine R., and Rothman P. STF-IL-4: a novel IL-4-induced signal transducing factor. EMBO J. 13 (1994) 1350-1356
253. Schleimer R.P., Sterbinsky S.A., Kaiser J., Bickel C.A., Klunk D.A., Tomioka K., Newman W., Luscinskas F.W., Gimbrone M.A., McIntyre B.W., and Bochner B.S. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J. Immunol. 148 (1992) 1086-1092
254. Schmitt E., Fassbender B., Beyreuther K., Spaeth E., Schwarzkopf R., and Rude E. Characterization of a T-cell-derived lymphokine that acts synergistically with IL-3 on the growth of murine mast cells and is identical with IL-4. Immunobiology 174 (1987) 406-419
255. Schmitz J., Thiel A., Kühn R., Rajewsky K., Müller W., Assenmacher M., and Radbruch A. Induction of interleukin 4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-Th cells. J. Exp. Med. 179 (1994) 1349-1353
256. Schuitemaker H., Kootstra N.A., Koppelman M.H.G.M., Bruisten S.M., Huisman H.G., Tersmette M., and Miedema F. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J. Clin. Invest. 89 (1992) 1154-1160
257. Schurmans S., Heusser C.H., Qin H., Merino J., Brighouse G., and Lambert P. In vivo effects of anti-IL-4 monoclonal antibody on neonatal induction of tolerance and on an associated autoimmune syndrome. J. Immunol. 145 (1990) 2465-2473
258. + T cells from allergic individuals. J. Exp. Med. 178 (1993) 2123-2130
259. + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 181 (1995) 1081-1089
260. + T helper type 2 cells. J. Exp. Med. 181 (1995) 5-7
261. Seder R.A., Paul W.E., Davis M.M., and Fazekas de St. Groth B.F. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 176 (1992) 1091-1098
262. Shapira S.K., Jabara H.H., Thienes C.P., Ahern D.J., Vercelli D., Gould H.J., and Geha R.S. Deletional switch recombination occurs in interleukin-4 induced isotype switching to IgE expression by human B cells. Proc. Natl. Acad. Sci. USA 88 (1991) 7528-7532
263. Shapira S.K., Vercelli D., Jabara H.H., Fu S.M., and Geha R.S. Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J. Exp. Med. 175 (1992) 289-292
264. Shields J.G., Armitage R.J., Jamieson B.N., Beverley P.C.L., and Callard R.E. Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4. Immunol. 66 (1989) 224-227
265. Shipp M.A., and Look A.T. Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key!. Blood 82 (1993) 1052-1070
266. Sideras P., and Palacios R. Bone marrow pro-T and pro-B lymphocyte clones express functional receptors for interleukin (IL)3 and IL-4/BSF-1 and nonfunctional receptors for IL2. Eur. J. Immunol. 17 (1987) 217-221
267. Sideras P., Funa K., Zalcberg-Quintana I., Xanthopoulos K.G., Kisielow P., and Palacios R. Analysis by in situ hybridization of cells expressing mRNA for interleukin 4 in the developing thymus and in peripheral lymphocytes from mice. Proc. Natl. Acad. Sci. USA 85 (1988) 218-221
268. Sillaber C., Strobl H., Bevec D., Ashman L.K., Butterfield J.H., Lechner K., Maurer D., Bettelheim P., and Valent P. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J. Immunol. 147 (1991) 4224-4228
269. (suppl). Sillaber C., Sperr W.R., Agis H., Geissler K., Spanblöchl E., Ashman L.K., Bettelheim P., and Lechner K. IL-4 inhibits SCF-dependent growth of human mast cells and downregulates c-kit expression. Blood 80 (1992) 92a
270. Simons A., and Zharhary D. The role of IL-4 in the generation of B lymphocytes in the bone marrow. J. Immunol. 143 (1989) 2540-2545
271. Smeland E.B., Blomhoff H.K., Funderud S., Shalaby M.R., and Espevik T. Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes. J. Exp. Med. 170 (1989) 1463-1468
272. Smerz-Bertling C., and Duschl A. Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J. Biol. Chem. 270 (1995) 966-970
273. Smirnov D.V., Smirnova M.G., Korobko V.G., and Frolova E.I. Tandem arrangement of human genes for interleukin-4 and interleukin-13: Resemblance in their organization. Gene 155 (1995) 277-281
274. Smith C.A., and Rennick D.M. Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3. Proc. Natl. Acad. Sci. USA 83 (1986) 1857-1861
275. Snoeck H.-W., Lardon F., Lenjou M., Nys G., Van Bockstaele D.R., and Peetermans M.E. Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-γ. Exp. Hematol. 21 (1993) 1480-1486
276. Snoeck H.-W., Lardon F., Lenjou M., Nys G., Van Bockstaele D.R., and Peetermans M.E. Interferon-γ and interleukin-4 reciprocally regulate the production of monocytes/macrophages and neutrophils through a direct effect on committed monopotential bone marrow progenitor cells. Eur. J. Immunol. 23 (1993) 1072-1077
277. Sonoda Y., Okuda T., Yokota S., Maekawa T., Shizumi Y., Nishigaki H., Misawa S., Fujii H., and Abe T. Actions of human interleukin-4/B-cell stimulatory factor-1 on proliferation and differentiation of enriched hematopoietic progenitor cells in culture. Blood 75 (1990) 1615-1621
278. Sonoda Y., Kuzuyama Y., Tanaka S., Yokota S., Maekawa T., Clark S.C., and Abe T. Human interleukin-4 inhibits proliferation of megakaryocyte progenitor cells in culture. Blood 81 (1993) 624-630
279. Sorg R.V., Enczmann J., Sorg U.R., Schneider E.M., and Wernet P. Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2. Exp. Hematol. 21 (1993) 560-563
280. Souillet G., Rousset F., and de Vries J.E. Alpha-interferon treatment of patient with hyper IgE syndrome. Lancet 1 (1989) 1384
281. Spits H., Yssel H., Takebe Y., Arai N., Yokota T., Lee F., Arai K., Banchereau J., and de Vries J.E. Recombinant interleukin-4 promotes the growth of human T cells. J. Immunol. 135 (1987) 1142-1147
282. Spits H., Yssel H., Paliard X., Kastelein R., Figdor D., and de Vries J.E. Interleukin-4 inhibits interleukin-2 mediated induction of human lymphokine activated killer cells, but not the generation of antigen specific cytotoxic T lymphocytes in mixed leucocyte cultures. J. Immunol. 141 (1988) 29-36
283. Sunder-Plassmann R., Majdiç O., Knapp W., and Holter W. High IL-4 production is a stable phenotype of CD8negCD45RAnegCD45RAnegCD27neg T cells. Cell. Immunol. 160 (1995) 309-313
284. Swain S.L., Bradley L.M., Croft M., Tonkonogy S., Atkins G., Weinberg A.D., Duncan D.D., Hedrick S.M., Dutton R.W., and Huston G. Helper T-cell subsets: Phenotype, function and the role of lymphokines in regulating their development. Immunol. Rev. 123 (1991) 115-144
285. Szabo S.J., Gold J.S., Murphy T.L., and Murphy K.M. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells. Mol. Cel. Biol. 13 (1993) 4793-4805
286. Takai S., Tateno M., Hirano T., Kondo N., Hirose S., and Yoshiki T. Increased IgE level as a marker of host-versus-graft disease: Inhibition of this HVGD with a monoclonal antibody to IL-4. Cell. Immunol. 149 (1993) 1-10
287. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinase. Science 268 (1995) 251-255
288. Te Velde A.A., Rousset F., Péronne C., de Vries J.E., and Figdor C. IL-4 induced expression of Fce{open}RIIb and soluble Fce{open}RIIb release from human monocytes is downregulated by IFNα and IFNγ. J. Immunol. 144 (1990) 3052-3059
289. Te Velde A.A., Klomp J.P.G., Yard B.A., de Vries J.E., and Figdor C.G. Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J. Immunol. 140 (1988) 1548-1554
290. Tepper R.I., Pattengale P.K., and Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57 (1989) 503-512
291. Tepper R.I., Levinson D.A., Stanger B.Z., Campos-Torres J., Abbas A.K., and Leder P. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 62 (1990) 457-467
292. Tepper R.I., Coffman R.L., and Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257 (1992) 548-551
293. Thompson C.B. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?. Cell 81 (1995) 979-982
294. Thompson-Snipes L., Dhar V., Bond M.W., Mosmann T.R., Moore K.W., and Rennick D. Interleukin-10: A novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173 (1991) 507
295. Thornhill M.H., and Kaskard D.O. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-γ. J. Immunol. 145 (1990) 865-872
296. Thornhill M.H., Kyan-Aung U., and Haskard D.O. IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. J. Immunol. 144 (1990) 3060-3065
297. Thornhill M.H., Wellicome S.M., Mahiouz D.L., Lanchbury J.S.S., Kyan-Aung U., and Haskard D.O. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and-independent binding mechanisms. J. Immunol. 146 (1991) 592-598
298. Todd M.D., Grusby M.J., Lederer J.A., Lacy E., Lichtman A.H., and Glimcher L.H. Transcription of the interleukin 4 gene is regulated by multiple promoter elements. J. Exp. Med. 177 (1993) 1663-1674
299. Toi M., Bicknell R., and Harris A.L. Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res. 52 (1992) 275-279
300. Topp M.S., Koenigsmann M., Mire-Sluis A., Oberberg D., Eitelbach F., Von Marschell Z., Notter M., Reufi B., Stein H., Thiel E., and Berdel W.E. Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo. Blood 82 (1993) 2837-2844
301. Topp M.S., Papadimitriou C.A., Eitelbach F., Koenigsmann M., Oelmann E., Koehler B., Oberberg D., Reufi B., Stein H., Thiel E., and Berdel W.E. Recombinant human interleukin-4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies. Cancer Res. 55 (1995) 2173-2176
302. Tsuji K., Nakahata T., Takagi M., Kobayashi T., Ishiguro A., Kikuchi T., Naganuma K., Koike K., Miyajima A., Arai K., and Akabane T. Effects of interleukin 3 and interleukin 4 on the development of connective tissue type mast cells: Interleukin 3 supports their survival and interleukin 4 triggers and supports their proliferation synergistically with interleukin 3. Blood 75 (1990) 421-427
303. Tushinski R.J., Larsen A., Park L.S., and Spoor E. Interleukin 4 alone or in combination with interleukin 1 stimulates 3T3 fibroblasts to produce colony-stimulating factors. Exp. Hematol. 19 (1991) 238-244
304. Ueno Y., Boone T., and Uittenbogaart C.H. Selective stimulation of human thymocyte subpopulations by recombinant IL-4 and IL-3. Cell. Immunol. 118 (1989) 382-393
305. Ushiyama C., Hirano T., Miyajima H., Okumura K., Ovary Z., and Hashimoto H. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. J. Immunol. 154 (1995) 2687-2696
306. Valent P., Bevec D., Maurer D., Besemer J., Di Padova F., Butterfield J.H., Speiser W., Majdic O., Lechner K., and Bettelheim P. Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Immunol. 88 (1991) 3339-3342
307. Vallé A., Zuber C.E., Defrance T., Djossou O., De Rie M., and Banchereau J. Activation of human B lymphocytes through CD40 and interleukin 4. Eur. J. Immunol. 19 (1989) 1463-1467
308. Vallé A., Aubry J.-P., Durand I., and Banchereau J. IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28: An amplification mechanism for T-B cell interactions. Int. Immunol. 3 (1991) 229-235
309. Van Hal P.T.W., Hopstaken-Broos J.P.M., Prins A., Favaloro E.J., Huijbens R.J.F., Hilvering C., Figdor C.G., and Hoogsteden H.C. Potential indirect anti-inflammatory effects of IL-4. Stimulation of human monocytes, macrophages, and endothelial cells by IL-4 increases aminopeptidase-N activity (CD13; EC3.4.11.2). J. Immunol. 153 (1994) 2718-2728
310. In press. Van Kooten C., and Banchereau J. CD40-CD40 ligand, a multifunctional receptor-ligand pair. J. Immunol. (1995)
311. Vannier E., Miller L.C., and Dinarello C.A. Coordinated anti-inflammatory effects of interleukin 4: IL-4 suppresses IL-1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA 89 (1992) 4076-4080
312. Varney V.A., Hamid Q.A., Gaga M., Ying S., Jacobson M., Frew A.J., Kay A.B., and Durham S.R. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen induced late phase cutaneous responses. J. Clin. Invest. 92 (1993) 644-651
313. Vellenga E., De Wolf J.T., Beentjes J.A.M., Esselink M.T., Smit J.W., and Haee M.R. Divergent effects of interleukin 4 (IL-4) on the granulocyte colony stimulating factor and IL-3 supported myeloid colony formation from normal and leukemic bone marrow cells. Blood 75 (1990) 633-637
314. Vellenga E., Dokter W., and Halie R.M. Interleukin-4 and its receptor: Modulating effects on immature and mature hematopoietic cells. Leukemia 7 (1993) 1131-1141
315. Vercelli D., Jabara H.H., Lee W., Woodland N., Geha R.S., and Leung D.Y.M. Human recombinant interleukin 4 induces Fce{open} R2/CD23 on normal human monocytes. J. Exp. Med. 167 (1988) 1406-1416
316. Vieira P., de Waal-Malefyt R., Dang M.N., Johnson K.E., Kastelein R., Fiorentino D.F., de Vries J.E., Roncarolo M.G., Mosmann T.R., and Moore K.W. Isolation and expression of human cytokine synthesis inhibitory factor (CSIF/IL-10) cDNA clones: Homology to Epstein-Barr Virus open reading frame BCRF1. Proc. Natl. Acad. Sci. USA 88 (1991) 1172-1176
317. Vita N., Lefort S., Laurent P., Caput D., and Ferrara P. Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J. Biol. Chem. 270 (1995) 3512-3517
318. Vollenweider S., Saurat J.-H., Röcken M., and Hauser C. Evidence suggesting involvement of interleukin-4 (IL-4) production in spontaneous in vitro IgE synthesis in patients with atopic dermatitis. J. Allergy Clin. Immunol. 87 (1991) 1088-1095
319. Wagteveld A.J., van Zanten A.K., Esselink M.T., Halie M.R., and Vellenga E. Expression and regulation of IL-4 receptors on human monocytes and acute myeloblastic leukemic cells. Leukemia 5 (1991) 782-788
320. Wagteveld A.J., Esselink M.T., Limburg P., Halie M.R., and Vellenga E. The effects of IL-1β and IL-4 on the proliferation and endogenous secretion of growth factors by acute myeloblastic leukemic cells. Leukemia 6 (1992) 1020-1024
321. Walter M.R., Cook W.J., Zhao B.G., Cameron R.P., Ealick S.E., Walter R.L., Reichert P., Nagabhushan T.L., Trotta P.P., and Bugg C.E. Crystal structure of recombinant human interleukin-4. J. Biol. Chem. 267 (1992) 20371-20376
322. Wang L.-M., Keegan A.D., Paul W.E., Heidaran M.A., Gutkind J.S., and Pierce J.H. IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells. EMBO J. 11 (1992) 4899-4908
323. Wang L.-M., Keegan A.D., Li W., Lienhard G.E., Pacini S., Gutkind J.S., Myers M.G., Sun X.-J., White M.F., Aaronson S.A., Paul W.E., and Pierce J.H. Common elements in interleukin-4 and insulin signaling pathways in factor-dependent hematopoietic cells. Proc. Natl. Acad. Sci. USA 90 (1993) 4032-4036
324. Warren H.S., Kinnear B.F., Phillips J.H., and Lanier L.L. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J. Immunol. 154 (1995) 5144-5152
325. Watanabe K., Tanaka Y., Morimoto I., Yahata K., Zeki K., Fujihira T., Yamashita U., and Eto S. Interleukin-4 as a potent inhibitor of bone resorption. Bioch. Bioph. Res. Comm. 172 (1990) 1035-1041
326. Wegrowski Y., Paltot V., Gillery P., Kalis B., Randoux A., and Maquart F.X. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4. Biochem. J. 307 (1995) 673-678
327. Wertheim W.A., Kunkel S.L., Standiford T.J., Burdick M.D., Becker F.S., Wilke C.A., Gilbert A.R., and Strieter R.M. Regulation of neutrophil-derived IL-8: The role of prostaglandin E2, dexamethasone, and IL-4. J. Immunol. 151 (1993) 2166-2175
328. White M.F., and Kahn C.R. The insulin signaling system. J. Biol. Chem. 269 (1994) 1-4
329. Widmer M.B., Acres R.B., Sassenfeld H.M., and Grabstein K.H. Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (Interleukin 4). J. Exp. Med. 166 (1987) 1447-1455
330. Widmer M.B., and Grabstein K.H. Regulation of cytolytic T lymphocyte generation by B-cell stimulatory factor. Nature 326 (1987) 795-798
331. Windsor W.T., Syto R., Durkin J., Das P., Reichert P., Pramanik B., Tindall S., Le H.V., Labdon J., Nagabhushan T.L., and Trotta P.P. Disulfide bond assignment of mammalian cell-derived recombinant human interleukin 4. Biophys. J. 57 (1990) 423a
332. Witte P.L., Frantsve L.M., Hergott M., and Rahbe S.M. Cytokine production and heterogeneity of primary stromal cells that support B lymphopoiesis. Eur. J. Immunol. 23 (1993) 1809-1817
333. Witthuhn B.A., Silvennoinen O., Miura O., Lai K.S., Cwik C., Liu E.T., and Ihle J.N. Involvement of the Jak-3 Janus kinase in signalling by interleukin 2 and 4 in lymphoid and myeloid cells. Nature 370 (1994) 153-157
334. Yin T., Tsang M.L.-S., and Yang Y.-C. JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes. J. Mol. Biol. 269 (1994) 26614-26617
335. Yokota T., Otsuka T., Mosmann T., Banchereau J., Defrance T., Blanchard D., de Vries J.E., Lee F., and Arai K. Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell-stimulatory activities. Proc. Natl. Acad. Sci. USA 83 (1986) 5894-5898
336. Yokota A., Kikutani H., Tanaka T., Sato R., Barsumian E.L., Suemura M., and Kishimoto T. Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): Tissue-specific and IL-4-specific regulation of gene expression. Cell 55 (1988) 611-618
337. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179 (1994) 1285-1295
338. Zhang K., Mills F.C., and Saxon A. Switch circles from IL-4-directed epsilon class switching from human B lymphocytes. Evidence for direct, sequential, and multiple step sequential switch from μ to e{open} Ig heavy chain gene. J. Immunol. 152 (1994) 3427-3435
339. Zlotnik A., Fischer M., Roehm N., and Zipori D. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: Enhancement of antigen presenting ability of bone marrow-derived macrophages. J. Immunol. 138 (1987) 4275-4279
340. Zlotnik A., Ramsom J., Franck G., Fischer M., and Howard M. Interleukin 4 is a growth factor for activated thymocytes: Possible role in T cell ontogeny. Proc. Natl. Acad. Sci. USA 84 (1987) 3856-3860
341. Zurawski G., and de Vries J.E. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15 (1994) 19-26
342. Zurawski S.M., Vega Jr. F., Huyghe B., and Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12 (1993) 2663-2670
343. Zurawski S.M., Chomarat P., Djossou O., Bidaud C., McKenzie A.N.J., Miossec P., Banchereau J., and Zurawski G. The primary binding subunit of the human interleukin-4 receptor is also a component of the Interleukin-13 receptor. J. Biol. Chem. 270 (1995) 13869-13878